Envara Health

Envara Health is a private, GI-focused medical nutrition company developing and commercializing clinically validated products for patients with fat malabsorption and related digestive disorders. Its lead and apparently only marketed product is Encala, a structured-lipid powdered medical food designed to improve fat absorption and nutritional status, particularly in people with cystic fibrosis and exocrine pancreatic insufficiency. The company was founded by Virginia Stallings, MD, and Jim O'Connell, and is based in the Philadelphia-area suburb of Malvern, Pennsylvania. Envara positions itself at the intersection of nutrition, digestive disease, and clinically supported non-drug interventions, with technology licensed in part from National Jewish Health and further developed internally through its Theradux platform. Publicly available information suggests Envara is a small private company with a focused commercial portfolio rather than a broad traditional therapeutics pipeline.